The coronavirus vaccine volunteer: 'I hope this is a kick up the ass to do things better'
Both benevolence and selfishness inspired Josh McGrane to take part in the University of Oxford vaccine trialsCoronavirus – latest updatesSee all our coronavirus coverageThe world is watching the Covid-19 vaccine trials conducted by the University of Oxford ’sJenner Institute closely. AustralianJosh McGrane is an associate professor and educational researcher living in Oxford. He decided to take part in the trials when he saw the call-out for volunteers on Facebook earlier this year.Why did you get involved?It was a mix of selfishness and benevolence. This was in March, everything was kicking off in the UK and ...
Source: Guardian Unlimited Science - September 19, 2020 Category: Science Authors: As told to Alexandra Spring Tags: Vaccines and immunisation Coronavirus outbreak Australia news University of Oxford Australian media Science Health Source Type: news

Phase-III trial of Oxford vaccine to begin in Pune next week
The SII has partnered with British-Swedish pharma company AstraZeneca for manufacturing the COVID-19 vaccine candidate, developed by the University of Oxford. (Source: The Economic Times)
Source: The Economic Times - September 19, 2020 Category: Consumer Health News Source Type: news

Leading BAME recruitment to research study
RPS English Pharmacy Board member Professor Mahendra Patel has been recruited by Oxford University’s PRINCIPLE trial as National BAME Community and Pharmacy Lead. The trial is evaluating whethe (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - September 18, 2020 Category: Drugs & Pharmacology Source Type: news

Human genetics: A look in the mirror
(Molecular Biology and Evolution (Oxford University Press)) Genome Biology and Evolution's latest virtual issue highlights recent research published in the journal within the field of human genetics. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - September 18, 2020 Category: Biology Source Type: news

September's normal increase in coughs and colds causing 'utter chaos' in post-lockdown Britain
Professor Carl Heneghan, a former doctor and now Oxford University researcher, said in Parliament's Science and Technology Committee today that coughs always spike in September. (Source: the Mail online | Health)
Source: the Mail online | Health - September 17, 2020 Category: Consumer Health News Source Type: news

Illness In Paused AstraZeneca Trial Likely Wasn ’t Caused By Vaccine, Oxford University Says
“After independent review, these illnesses were either considered unlikely to be associated with the vaccine or there was insufficient evidence to say for certain that the illnesses were or were not related to the vaccine.” (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - September 17, 2020 Category: Pharmaceuticals Authors: Rachel Sandler, Forbes Staff Tags: Business /business Innovation /innovation Healthcare /healthcare Breaking breaking-news Source Type: news

Leveraging Research for Solution-driven Policymaking in the Era of COVID-19
By Sudip Ranjan Basu, Monica Das, Alexandra Boakes Tracy and Achim WennmannBANGKOK, Thailand, Sep 16 2020 (IPS) The United Nations has tasked the Canadian Institutes of Health Research Institute of Population and Public Health (CIHR-IPPH) to lead the research roadmap to identify priorities that will support an equitable global socio-economic recovery from COVID-19 within the broader framework of the Sustainable Development Goals (SDGs). As the world grapples with the impacts of COVID-19, identifying the research agenda and partnering with academic institutions and think tanks have become more essential than ever before. S...
Source: IPS Inter Press Service - Health - September 16, 2020 Category: International Medicine & Public Health Authors: Sudip Ranjan Basu - Monica Das - Alexandra Boakes Tracy - Ac Tags: Asia-Pacific Development & Aid Economy & Trade Global Headlines Health Human Rights Humanitarian Emergencies Poverty & SDGs TerraViva United Nations Source Type: news

Top Oxford professor behind Covid-19 vaccine reiterates safety is 'top of the list'
Sarah Gilbert, professor of vaccinology at Oxford University, said no corners were being cut when it came to ensuring that a vaccine was safe. (Source: the Mail online | Health)
Source: the Mail online | Health - September 15, 2020 Category: Consumer Health News Source Type: news

Central Europe Largely Avoided the First Coronavirus Wave. Why Are Cases Spiking Now?
Central Europe in the past week has seen a spike in daily confirmed coronavirus cases, a major setback for a region that largely avoided the first wave of the virus in the spring. The Czech Republic, an E.U. member state of 10.7 million, registered a country record of 1,382 new infections on Sep. 11, bringing the country’s total cases to over 32,400. In the last week, nearby countries Hungary, Slovakia and Slovenia have also recorded their highest daily caseloads since the pandemic began. Infections in the Czech Republic previously peaked at around 3 cases per capita (per 100,000 residents) in late March but reached ...
Source: TIME: Health - September 15, 2020 Category: Consumer Health News Authors: Madeline Roache Tags: Uncategorized COVID-19 europe Explainer Londontime Source Type: news

AstraZeneca COVID-19 Vaccine Trial Restarts
MONDAY, Sept. 14, 2020 -- Oxford University has announced that final-stage testing of a COVID-19 vaccine it is developing with drug maker AstraZeneca will restart following a pause last week after a serious side effect showed up in a... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - September 14, 2020 Category: Pharmaceuticals Source Type: news

Oxford University to test Regeneron's 'antibody cocktail' on hospitalised Covid-19 patients
Hospitals in Britain will trial a therapy created by US-based company Regeneron, which has designed treatment based on immune system antibodies taken from actual Covid-19 survivors. (Source: the Mail online | Health)
Source: the Mail online | Health - September 14, 2020 Category: Consumer Health News Source Type: news

AstraZeneca COVID Vaccine Trial Restarts
MONDAY, Sept. 14, 2020 (Healthday News) -- Oxford University has announced that final-stage testing of a coronavirus vaccine it is developing with drug maker AstraZeneca will restart following a pause last week after a serious side effect showed up... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - September 14, 2020 Category: General Medicine Source Type: news

Vaccine Makers Keep Safety Details Quiet, Alarming Scientists
Researchers say drug companies need to be more open about how vaccine trials are run to reassure Americans who are skittish about getting a coronavirus vaccine. (Source: NYT Health)
Source: NYT Health - September 14, 2020 Category: Consumer Health News Authors: Katie Thomas Tags: Clinical Trials Vaccination and Immunization Drugs (Pharmaceuticals) Coronavirus (2019-nCoV) Research AstraZeneca PLC Food and Drug Administration Moderna Inc Oxford University Pfizer Inc Krumholz, Harlan M Offit, Paul A Trump, Don Source Type: news

Oxford University resumes Covid-19 vaccine trials
Trials of vaccine being developed with AstraZeneca had been paused after participant fell illCoronavirus – latest updatesSee all our coronavirus coverageThe closely watched trial of an experimental Covid-19 vaccine that was halted after a participant fell ill is to resume in the UK.The University of Oxford, which has partnered with pharmaceutical giant AstraZeneca to pilot the study, said that the UK Medicines and Healthcare Products Regulatory Agency (MHRA) had recommended that its trials resume after an independent committee review of safety data triggered a pause last week.Continue reading... (Source: Guardian Unlimited Science)
Source: Guardian Unlimited Science - September 13, 2020 Category: Science Authors: Jamie Doward Tags: Coronavirus outbreak Vaccines and immunisation UK news AstraZeneca Health Pharmaceuticals industry Source Type: news

Coronavirus live news: France daily cases top 10,000; Victoria reports 41 new infections
Cases also rising in England and Scotland as Europe outbreak worsens; seven more deaths in worst-hit Australian state; Oxford University vaccine trials to resume. Follow latest updatesOxford University resumes Covid-19 vaccine trialsTrump ally who tried to change Covid reports was ‘fighting deep state’Australian diplomats sent to Heathrow to help stranded citizens4.45amBSTBack inVictoria, Australia:A woman dragged from her car by police on Saturday is expected to be charged with six offences, including resisting arrest and assaulting a police officer.Police spoke to the female driver at the checkpoint in relati...
Source: Guardian Unlimited Science - September 13, 2020 Category: Science Authors: Ben Doherty (now), Alison Rourke and Martin Farrer (earlier) Tags: Coronavirus outbreak UK news US news Australia news India Brazil Science Source Type: news

AstraZeneca's Oxford vaccine trial to resume, the university says
The AstraZeneca coronavirus vaccine trial, halted last week after an unexplained illness in one of the volunteers, will resume, the University of Oxford announced Saturday. (Source: CNN.com - Health)
Source: CNN.com - Health - September 13, 2020 Category: Consumer Health News Source Type: news

Coronavirus: Oxford University to resume vaccine trial after pause
The late-stage trials were paused due to a reported side effect in a patient in the UK. (Source: BBC News | Health | UK Edition)
Source: BBC News | Health | UK Edition - September 12, 2020 Category: Consumer Health News Source Type: news

Coronavirus: Oxford University resumes vaccine trial; cases in Scotland hit four-month high - live updates
India racks up another 97,570 infections; police disperse demonstrators in Victoria; Brazil deaths climb past 130,000. Follow all the developmentsCovid-19 vaccine gamble: where bets have been placed and why‘World-leadingly bad’: the week Covid resurged in the UKPassengers furious at airlines over voucher policyBob Woodward rejects criticism he sat on Trump ‘deadly’ virus remarks2.41pmBSTDaily coronavirus cases inScotland have hit a four-month high, the latest Scottish government figures show.A total of 221 people have tested positive for the virus in the past 24 hours - the highest daily figure sinc...
Source: Guardian Unlimited Science - September 12, 2020 Category: Science Authors: Damien Gayle , Graham Readfearn and Naaman Zhou (earlier), Aaron Walawalkar(now) Tags: Coronavirus outbreak Infectious diseases Science Medical research Microbiology World news Source Type: news

Drug regulator asks Serum Institute to increase safety monitors of Covid drug trials
A day after the company halted the trial of the AstraZeneca-Oxford University Covid vaccine in the country. The Drug controller has asked the Pune based company to suspend any new recruitment in the Phase II/III trial till further orders. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - September 12, 2020 Category: Pharmaceuticals Source Type: news

Africa: Why Halting the Covid-19 Vaccine Trial Is Part of the Process
[The Conversation Africa] This week the University of Oxford and Astra Zeneca temporarily postponed further vaccination in clinical trials of the COVID-19 candidate vaccine, AZD1222, after one of the participants fell ill. There are more than 15,000 participants already enrolled across multiple studies of the vaccine in several countries around the world, including 1,800 in South Africa. The Conversation Africa's health and medicine editor, Ina Skosana, asked Professor Shabir Madhi, who is leading the South African leg of the trial (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - September 11, 2020 Category: African Health Source Type: news

Show more empathy to boost confidence in vaccines, scientists told
Expert behind vaccine confidence report points to halting of Oxford Covid trial as exampleDoctors and scientists need to show more empathy towards volunteers in coronavirus vaccine trials who fall ill if the public is to have full confidence in the safety of the vaccines being developed, say experts.The temporary halting of theOxford University/AstraZeneca trial after one volunteer in the UK was admitted to hospital was good news, not bad, said Heidi Larson, who leads the Vaccine Confidence Project at the London School of Hygiene and Tropical Medicine, as it showed that scientists and the company were putting safety first....
Source: Guardian Unlimited Science - September 11, 2020 Category: Science Authors: Sarah Boseley Health editor Tags: Coronavirus outbreak Vaccines and immunisation Health Infectious diseases Medical research Science Society World news UK news AstraZeneca Pharmaceuticals industry University of Oxford Source Type: news

The Great Vaccine Race: Inside the Unprecedented Scramble to Immunize the World Against COVID-19
The cleverest of enemies thrive on surprise attacks. Viruses—and coronaviruses in particular—know this well. Remaining hidden in animal hosts for decades, they mutate steadily, sometimes serendipitously morphing into more effective and efficient infectious agents. When a strain with just the right combination of genetic codes that spell trouble for people makes the leap from animal to human, the ambush begins. Such was the case with SARS-CoV-2, the coronavirus behind COVID-19, and the attack was mostly silent and insidious at first. Many people infected with SARS-CoV-2 remained oblivious as they served as the v...
Source: TIME: Health - September 10, 2020 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized COVID-19 Magazine Source Type: news

Don't jump to conclusions about the Oxford vaccine trial suspension | Charlotte Summers
This review process is evidence of rigorous safety measures. As the fight against coronavirus continues, speculation is the last thing anyone needsThe Oxford trial, one of the most advanced of the major global programmes to find a vaccine for Sars-CoV-2, has beenpaused, resulting in much speculation about why, and what this might mean for our efforts to control the pandemic. Is this a cause for concern? Unsettling as some of the headlines may seem, in my opinion we should not be unduly worried.Vaccines are some of the most rigorously scrutinised of all healthcare products. In the UK, clinical trials of vaccines (and medici...
Source: Guardian Unlimited Science - September 10, 2020 Category: Science Authors: Charlotte Summers Tags: Coronavirus outbreak Vaccines and immunisation University of Oxford Health Infectious diseases Science Society UK news Source Type: news

Oxford Covid-19 vaccine is still possible this year, says AstraZeneca chief
Pharmaceutical firm ’s boss says 2020 deadline possible if regulators move fastCoronavirus – latest updatesSee all our coronavirus coverageAstraZeneca ’s coronavirus vaccine could still be available by the end of the year, or early next year, according to the company’s chief executive, Pascal Soriot, despite clinical trials being paused after a volunteer fell ill.AstraZeneca and Oxford University, which are jointly developing the vaccine and testing it on 50,000 to 60,000 people around the world,halted trialson Wednesday to investigate the “potentially unexpected illness” of one particip...
Source: Guardian Unlimited Science - September 10, 2020 Category: Science Authors: Julia Kollewe Tags: AstraZeneca University of Oxford Pharmaceuticals industry Coronavirus outbreak Business Infectious diseases Medical research World news UK news Vaccines and immunisation Society Science Health Source Type: news

Covid-19: We have no idea where vaccine will come from, says expert
Comments follow news of delay to Oxford trial after one of UK volunteers fell illCoronavirus – latest updatesSee all our coronavirus coverageNobody can know where the first safe and effective vaccine against Covid-19 will come from, warned one of the UK ’s leading medical experts, as the trials of the frontrunner, from Oxford University, were put on hold.The Oxford vaccine appeared to be storming ahead, amid hopes it would have the data to get it approved by a regulator before the end of the year. Last month, Donald Trump was said to be considering pushing for it to be fast-tracked in the US before the presiden...
Source: Guardian Unlimited Science - September 10, 2020 Category: Science Authors: Sarah Boseley and agencies Tags: Coronavirus outbreak Infectious diseases Matt Hancock Science Medical research World news UK news Source Type: news

Drugs bill warning over US/UK trade deal
(SAGE) The NHS would spend billions of pounds more on drugs if it had to pay US prices following a US/UK trade deal. According to a new study by researchers at Brigham and Women's Hospital in Boston, Harvard Medical School, and the University of Oxford, NHS England would have spent over £ 5 billion more on 50 brand-name prescription drugs widely used in primary care if it had paid US prices in 2018. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - September 10, 2020 Category: International Medicine & Public Health Source Type: news

We have no idea where Covid-19 vaccine will come from, says expert
Comments follow news of delay to Oxford trial after one of UK volunteers fell illCoronavirus – latest updatesSee all our coronavirus coverageNobody can know where the first safe and effective vaccine against Covid-19 will come from, warned one of the UK ’s leading medical experts, as the trials of the frontrunner, from Oxford University, were put on hold.The Oxford vaccine appeared to be storming ahead, amid hopes it would have the data to get it approved by a regulator before the end of the year. Last month, Donald Trump was said to be considering pushing for it to be fast-tracked in the US before the presiden...
Source: Guardian Unlimited Science - September 10, 2020 Category: Science Authors: Sarah Boseley and agencies Tags: Coronavirus outbreak Infectious diseases Matt Hancock Science Medical research World news UK news Source Type: news

AstraZeneca's COVID-19 vaccine trial halted following "serious adverse reaction" involving spinal inflammation
(Natural News) A participant in AstraZeneca and the University of Oxford‘s Wuhan coronavirus (COVID-19) vaccine trial has suffered a “serious adverse reaction,” prompting the Operation Warp Speed experiment to come to an immediate halt. Dozens of testing sites around the world are no longer injecting human subjects with the chemical solution after this individual reportedly... (Source: NaturalNews.com)
Source: NaturalNews.com - September 10, 2020 Category: Consumer Health News Source Type: news

AstraZeneca Paused Its COVID-19 Vaccine Trial to Perform a Safety Review. That ’s Not Bad News
AstraZeneca, the U.K.-based pharmaceutical company behind one of the world’s most promising COVID-19 vaccine candidates, has paused its trials due to “a single event of an unexplained illness that occurred in the UK Phase III trial,” the company announced Sept. 9. The news is disappointing, but it shows the development process is happening as it should. It is not uncommon for drug or vaccine trials to hit snags, even at advanced stages. Indeed, part of the reason vaccines go through multiple phases of testing, with increasingly large numbers of patients, is to catch rare but potentially serious side effec...
Source: TIME: Health - September 9, 2020 Category: Consumer Health News Authors: Jamie Ducharme Tags: Uncategorized COVID-19 Source Type: news

AstraZeneca Resumed Its COVID-19 Vaccine Trial After Pausing for Safety Review
This story has been updated to reflect AstraZeneca’s vaccine trial resuming. AstraZeneca, the U.K.-based pharmaceutical company behind one of the world’s most promising COVID-19 vaccine candidates, has resumed its U.K. trial after pausing it due to “a single event of an unexplained illness,” the company announced Sept. 12. While AstraZeneca did not initially specify the nature of the study participant’s “unexplained illness,” an anonymous source told the New York Times that a trial participant in the U.K. was recently diagnosed with an inflammatory condition that affects the spinal...
Source: TIME: Health - September 9, 2020 Category: Consumer Health News Authors: Jamie Ducharme Tags: Uncategorized COVID-19 Source Type: news

Oxford Covid vaccine trial suspension: what happens next?
Tests have been paused after a UK volunteer became ill. How will it affect the search for a cure?Coronavirus – latest updatesSee all our coronavirus coverageOne of the volunteers in the UK has become ill and it is crucial that the researchers find out whether this could be related to the vaccine. This is not uncommon in vaccine trials – and in fact it is said to be the second time it has happened with this drug. Very large trials are essential to pick up any rare side-effects. Something that affects one in 10,000 people, for instance, will probably not be detected in the early trials of just a few thousand.Cont...
Source: Guardian Unlimited Science - September 9, 2020 Category: Science Authors: Sarah Boseley Health editor Tags: Medical research Coronavirus outbreak Science Infectious diseases World news Microbiology University of Oxford AstraZeneca Business Pharmaceuticals industry Health Source Type: news

Oxford Covid-19 vaccine trial participant undeterred by pause
Man says he would continue with trial despite being worried about a second injectionCoronavirus – latest updatesSee all our coronavirus coverageA participant in the Oxford University coronavirus vaccine trial in the UK has said he is undeterred bya pause in the trial, which has been caused by an adverse reaction in one patient, and would continue to take part “in the name of science”.Joe Walters said he was concerned when news broke of the trial ’s suspension. He said he had reacted with a very high fever after his first injection and was worried about the second shot.Continue reading... (Source: Gu...
Source: Guardian Unlimited Science - September 9, 2020 Category: Science Authors: Helen Sullivan Tags: Coronavirus outbreak Vaccines and immunisation Infectious diseases Health Medical research Science World news Society Microbiology UK news Source Type: news

AstraZeneca pauses Covid-19 vaccine trial after suspected adverse event
AstraZeneca has paused all clinical trials of the Covid-19 vaccine it is developing with Oxford university after a participant in the UK section of the study suffered a suspected serious adverse reaction. Shares in the drugmaker slid after study of coronavirus jab put on hold to ‘review safety data.’ (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - September 9, 2020 Category: Pharmaceuticals Authors: Hannah Kuchler in New York and Sarah Neville in London Source Type: news

AstraZeneca's COVID-19 vaccine trials put on hold after suspected 'serious' reaction
On Tuesday, trials of thee COVID-19 vaccine being developed by Oxford University and AstraZeneca have been placed on a hold after a suspected dangerously bad reaction to the shot. (Source: the Mail online | Health)
Source: the Mail online | Health - September 9, 2020 Category: Consumer Health News Source Type: news

The Oxford University AstraZeneca Covid-19 vaccine trial has been paused – should we be worried?
Is this the end for hopes of an early breakthrough in the race to find a coronavirus drug?Thehalt in development of theUniversity of Oxford ’s Covid-19 vaccine due to an adverse reaction in a trial participant has triggered fears of a delay in finding a solution to coronavirus restrictions.A spokesman for AstraZeneca, the company working with the academic team to produce the vaccine, said the voluntary pause is “routine”.Continue reading... (Source: Guardian Unlimited Science)
Source: Guardian Unlimited Science - September 9, 2020 Category: Science Authors: Elias Visontay Tags: Coronavirus outbreak Infectious diseases Microbiology Medical research University of Oxford Science Health Pharmaceuticals industry Drugs Source Type: news

Coronavirus: Oxford University vaccine trial paused after participant falls ill
AstraZeneca describes the pause in its keenly-awaited final clinical trials as routine. (Source: BBC News | Health | UK Edition)
Source: BBC News | Health | UK Edition - September 9, 2020 Category: Consumer Health News Source Type: news

Oxford University researchers discover 'genetic vulnerability' in breast cancer cells
(University of Oxford) The study, published in the scientific journal Nature, has uncovered a genetic vulnerability present in nearly 10% percent of all breast cancers tumours, and found a way to target this vulnerability and selectively kill cancer cells. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - September 9, 2020 Category: Cancer & Oncology Source Type: news

New way to target some rapidly dividing cancer cells, leaving healthy cells unharmed
(Johns Hopkins Medicine) Scientists at Johns Hopkins Medicine and the University of Oxford say they have found a new way to kill some multiplying human breast cancer cells by selectively attacking the core of their cell division machinery. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - September 9, 2020 Category: Cancer & Oncology Source Type: news

COVID-19 Vaccine Trial Paused Due To Illness In Volunteer
AstraZeneca, which is working with the University of Oxford, hasn't said what the illness is. It will try to determine whether the illness is related to the vaccine, or just a chance event.(Image credit: Alastair Grant/AP) (Source: NPR Health and Science)
Source: NPR Health and Science - September 9, 2020 Category: Consumer Health News Authors: Joe Palca Source Type: news

India trials of COVID-19 vaccine is going on: Serum Institute
Last month, the Drug Controller General of India had granted permission to the Pune-based SII to conduct Phase-II and -III human clinical trials of the coronavirus vaccine candidate developed by Oxford University and British-Swedish pharmaceutical firm AstraZeneca. (Source: The Economic Times)
Source: The Economic Times - September 9, 2020 Category: Consumer Health News Source Type: news

High blood pressure and diabetes 'can impair thinking and memory'
Scientists at the University of Oxford found that those suffering from the diseases had 'significant structural changes' in the brain's grey and white matter. The study was published in Nature Communications. (Source: the Mail online | Health)
Source: the Mail online | Health - September 8, 2020 Category: Consumer Health News Source Type: news

Two types of steroid found to save lives of some Covid-19 patients
Analysis of seven trials finds dexamethasone and hydrocortisone should be given in severe casesCoronavirus – latest updatesSee all our coronavirus coverageStudies around the world have confirmed that steroids can save lives in the Covid-19 pandemic, leading to new recommendations from the World Heath Organization that doctors should give them to severely ill patients.In June, the Recovery trial run in most NHS hospitals and led by Oxford University found that the lives of one in eight people sick enough from Covid-19 to need a ventilator could be saved by a steroid called dexamethasone.Continue reading... (Source: Gu...
Source: Guardian Unlimited Science - September 3, 2020 Category: Science Authors: Sarah Boseley Health editor Tags: Medical research Coronavirus outbreak Science World news Source Type: news

Prevention of suicide/self-harm in the context of COVID-19, NIHR
Please note all questions within each section are linked to each other and should be read in conjunction. Below each question is the weblink to the source of evidence to support the guidance recommendation. Readers can, of course, focus only on areas of interest, but we would suggest that you read the answers to all questions within a group as the answers complement and overlap with each other. The tables were created with input and guidance from Professor Keith Hawton (Professor of Psychiatry, Centre for Suicide Research, University of Oxford; Consultant Psychiatrist, Oxford Health NHS Foundation Trust), Dr Alexandra Pit...
Source: Current Awareness Service for Health (CASH) - September 2, 2020 Category: Consumer Health News Source Type: news

Bus drivers more likely to let white customers ride for free
(Oxford University Press USA) A new paper in The Economic Journal finds that bus drivers are more likely to let white riders ride for free and less likely to let Black riders ride without paying the fee. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - September 2, 2020 Category: International Medicine & Public Health Source Type: news

Men with waists over 40 inches 'are 35% more likely to die of prostate cancer'
The Oxford University study found a man with 40inch (103cm) waist or above has a 35 per cent higher risk of passing from the disease than one who wears a 35inch (90cm) or lower trouser size. (Source: the Mail online | Health)
Source: the Mail online | Health - September 2, 2020 Category: Consumer Health News Source Type: news

AstraZeneca begins final trials of Oxford University coronavirus vaccine enrolling 50,000 people
The world may be one step closer to getting a Covid-19 jab after Oxford's candidate entered its final stage of tests in the US. Thousands have already been injected in the UK, Brazil and South Africa. (Source: the Mail online | Health)
Source: the Mail online | Health - September 1, 2020 Category: Consumer Health News Source Type: news

AstraZeneca Covid-19 Coronavirus Vaccine Begins Phase 3 Trial In U.S.
The Phase 3 clinical trial will evaluate AstraZeneca ’s AZD1222 Covid-19 coronavirus vaccine candidate, which was originally developed at Oxford University. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - September 1, 2020 Category: Pharmaceuticals Authors: Bruce Y. Lee, Senior Contributor Tags: Healthcare /healthcare Innovation /innovation Business /business Editors' Pick editors-pick Coronavirus pharma Source Type: news

Pills to lower blood pressure can prevent heart attacks even in HEALTHY people
In the biggest study of its kind, Oxford University researchers found lowering levels even from a healthy starting point slashed the risk of heart disease and strokes by up to 13 per cent years down the line. (Source: the Mail online | Health)
Source: the Mail online | Health - August 31, 2020 Category: Consumer Health News Source Type: news

More Covid-19-like viruses to come, warns Oxford professor
Sarah Gilbert, the lead expert behind Oxford University's Covid vaccine, said modern lifestyles, intense farming and deforestation drove up the risk of outbreaks of zoonotic infections. (Source: the Mail online | Health)
Source: the Mail online | Health - August 31, 2020 Category: Consumer Health News Source Type: news

They Pledged to Donate Rights to Their COVID Vaccine They Pledged to Donate Rights to Their COVID Vaccine
"Why wouldn't people agree to let everyone have access to the best vaccines possible?" said the director of a nonprofit that works to expand access to medical technology, of Oxford University's pledge.Kaiser Health News (Source: Medscape Infectious Diseases Headlines)
Source: Medscape Infectious Diseases Headlines - August 26, 2020 Category: Infectious Diseases Tags: Pathology & Lab Medicine News Source Type: news